Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis
Physiological Reports · 2025
DOI: 10.14814/phy2.70489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Hassan Bur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Research Unit of Translational Medicine, University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Duodenum, Neuroendocrine Cells. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Foundation for Cardiovascular Research, Northern Finland Health Care Support Foundation, Finnish Government Grants for Health Research.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Duodenal endocrine cells contribute to the incretin response, yet their changes in obesity and type 2 diabetes (T2D) remain controversial. We quantified expression of chromogranin A, glucagon‐like peptide‐1 (GLP‐1), serotonin, and neuromedin U (NmU) in duodenal biopsies from 34 participants with obesity (19 with T2D, 15 without) and six healthy controls. Compared to controls, the patients with obesity showed significantly higher proportions of chromogranin A ( p = 0.007), GLP‐1 ( p = 0.006), and serotonin ( p = 0.013) expressing cells, irrespective of T2D status. GLP‐1 expression correlated with HbA1C ( r = 0.454, p = 0.005) and meal test glucose ( r = 0.455, p = 0.0018) but not with insulin. Chromogranin A expression correlated with both GLP‐1 ( r = 0.486, p = 0.003) and serotonin ( r = 0.475, p = 0.003), as well as BMI ( r = 0.429, p = 0.007). NmU was detected in the lamina propria but did not differ among groups. For NmU, an association with insulin (incremental AUC, r = 0.363, p = 0.045) was observed. In conclusion, obesity was associated with hyperplasia of duodenal GLP‐1, serotonin, and chromogranin A cells. The link between GLP‐1 expression, HbA1C, and meal test glucose indicates that, despite increased numbers of GLP‐1–producing cells, individuals with obesity may still experience insufficient incretin action. No evidence supported a role for NmU as a human decretin in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Research Unit of Translational Medicine, University of Oulu, Oulu, Finland.
- Department of Pathology, Oulu University Hospital, Oulu, Finland.
- Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
- Research Unit of Biomedicine and Internal Medicine, University of Oulu, Oulu, Finland.
- Department of Surgery, Oulu University Hospital, Oulu, Finland.
ORCID-Profile: Tuomo J Karttunen
Förderung
- Finnish Foundation for Cardiovascular Research
- Northern Finland Health Care Support Foundation
- Finnish Government Grants for Health Research
- Finnish Medical Foundation
Zitieren
APA
Bur, H., Hukkanen, J., Savolainen, M. J., Koivukangas, V., & Karttunen, T. J. (2025). Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis. Physiological Reports. https://doi.org/10.14814/phy2.70489
Vancouver
Bur H, Hukkanen J, Savolainen MJ, Koivukangas V, Karttunen TJ. Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis. Physiological Reports. 2025. doi:10.14814/phy2.70489
BibTeX
@article{Bur2025,
author = {Bur, Hassan and Hukkanen, Janne and Savolainen, Markku J and Koivukangas, Vesa and Karttunen, Tuomo J},
title = {Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70489}
}
EUVIMED